Process for producing 2,6-dihalogenopurine

Details Process for producing 2,6-dihalogenopurine Process for producing 2,6-dihalogenopurine

2008-01-22

2008-01-22

Berch, Mark L. (Department: 1624)

Organic compounds -- part of the class 532-570 series

Organic compounds

Nitrogen attached directly or indirectly to the purine ring...

Reexamination Certificate

active

07321035

ABSTRACT:
A process for conveniently and efficiently preparing a 2,6-dihalogenopurine using an inexpensive starting material. A process for preparing a 2,6-dihalogenopurine, comprising treating a 2-amino-6-halogenopurine having a protective group at 7thposition or 9thposition with a diazotizating agent and a halogen source; and a process for preparing a 9-acyl-2-amino-6-halogenopurine, comprising treating a 2-amino-6-halogenopurine with an acylating agent in the presence of a base.

REFERENCES:
patent: 3314938 (1967-04-01), Kawashima et al.
patent: 6093819 (2000-07-01), Hanson
patent: 6455696 (2002-09-01), Hayashi et al.
patent: 2004/0102459 (2004-05-01), Gillespie et al.
patent: 2005/0131229 (2005-06-01), Hayashi et al.
patent: 138683 (1985-04-01), None
patent: 0 433 845 (1991-06-01), None
patent: 1172365 (2002-01-01), None
patent: 904517 (1991-06-01), None
patent: 6-92965 (1994-04-01), None
Nathanael S. Gray et al.: “Combinational synthesis of 2, 9-substituted purines” Tetrahedron Letter, vol. 38, No. 7, pp. 1161-1164, 1997.
J. Warren Beach et al.: “A highly stereoselective synthesis of anti-HIV 2′, 3′-dideoxy- and 2′, 3′-didehydro-2′, 3′- dideoxynucleosides” J. Org. Chem., vol. 57, No. 14, pp. 3887-3894, 1992.
Suzanne E. Keeling et al.: “The discovery and synthesis of highly potent, A2areceptor agonists” Bioorganic & Medicinal Chemistry Letters, vol. 10, pp. 403-406, 2000.
Kazunori Niiya et al.: “2-(N′-alkylidenehydrazino) adenosines: Potent and selective coronary vasodilators” J. Med. Chem., vol. 35, No. 24, pp. 4557-4561, 1992.
B. Ha Seung et al.: “New base-altered adenosine analogues: synthesis and affinity at adenosine A1and A2Areceptors” Bioorganic & Medicinal Chemistry Letters, vol. 7, No. 24, pp. 3085-3090, Jan. 16, 2002.
Elizabeth Dyer et al.: “Acylations of some 2-amino-6-halo- and 2-amino-6-alkylthiopurines” J. Med. Chem., vol. 11, No. 6, pp. 1232-1234, 1968.
Radiochimiya, vol. 23, No. 4, pp. 607-613, 1981, with English translation.
Michael R. Harnden et al.: “Analogues of the antiviral acyclonucleoside 9-(4-hydroxy-3-hydroxymethylbutyl)guanine. Part 4. Substitution on the 2-amino group” J. Chem. Soc., Perkins Trans. 1, pp. 2207-2213, 1989.
Anupma Dhanda et. al.: “Facile conversion of 4-endo-hydroxy-2-oxablcyclo[3.3.0]oct-7-en-3-one into carbocyclic 2′- deoxyribonucleoside analogues” J. Chem. Soc., Perkins Trans. 1, pp. 3469-3475, 1999.
Vasu Nair, et al., “Modification of Nucleic Acid Bases Via Radical Intermediates: Synthesis Of Dihalogenated Purine Nucleosides,” Synthesis, vol. 8, 1982, pp. 670-672.
P. Francom, et al., “Nucleic Acid Related Compounds 116. Nonaqueous Diazotization of Aminopurine Nucleosides.” Journal of Organic Chemistry, vol. 67, No. 19, 2002, pp. 6788-6796.
Richard E. Austin, Tet. Letters 43 6169 (2002).
Robert H. Iwamoto, et al., 2′-Deoxythioguanosine And Related Nucleosides, Journal Of Medicinal Chemistry, vol. 6, pp. 684-688, 1963.

Affiliated with

Also associated with

Rating

Process for producing 2,6-dihalogenopurine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process for producing 2,6-dihalogenopurine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for producing 2,6-dihalogenopurine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2811067